Two major studies by leading research groups published in The New
England Journal of Medicine on Wednesday independently identified mutations in
a single gene that protect against heart attacks by keeping levels of
triglycerides — a kind of fat in the blood — very low for a lifetime. The
findings are expected to lead to a push to develop drugs that mimic the effect
of the mutations, potentially offering the first new class of drugs to combat
heart disease in decades.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment